Literature DB >> 15193958

Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs.

R Loch Macdonald1, Linda S Marton, Paula K Andrus, Edward D Hall, Lydia Johns, Michael Sajdak.   

Abstract

Vasospasm after subarachnoid hemorrhage (SAH) is associated with lipid peroxidation. However, lipid peroxides increase in a delayed fashion after SAH and may be a byproduct of but not a cause of vasospasm. This study correlated vasospasm with hydroxyl free radical and lipid peroxide levels. 24 dogs had baseline cerebral angiography and induction of SAH by 2 injections of blood into the cisterna magna at baseline and 2 days later. Angiography was repeated 4, 7, 10, 14 or 21 days after the first injection (n = 4 per group) and a microdialysis catheter was inserted into the premedullary cistern. Control dogs (n = 4) underwent angiography and microdialysis but not SAH. Salicylic acid, 100 mg/kg, was administered intravenously, and microdialysis fluid was collected and analyzed by high pressure liquid chromatography for 2,3- and 2,5-dihydroxybenzoic acids (DHBA). Malondialdehyde was measured in subarachnoid clot removed from the prepontine cistern and in the basilar artery itself at the time of euthanasia. Significant vasospasm developed 4 to 14 days after SAH. Malondialdehyde levels were significantly elevated in the basilar artery and subarachnoid clot 4 days after SAH (p < 0.0001, ANOVA) but not at other times. 2,5-DHBA levels were significantly greater than control at 4 to 14 days and they peaked at 4 days (p < 0.05, ANOVA). 2,3-DHBA was significantly increased at 4 days after SAH (p < 0.05, ANOVA). There were significant correlations between basilar artery malondialdehyde levels and vasospasm and cerebrospinal fluid 2,5-DHBA levels and vasospasm. These results suggest the presence of hydroxyl free radical after SAH and demonstrate a correlation between such production, as measured by trapping with salicylate, and the early phase of vasospasm. The correlation with vasospasm implicates free radicals and lipid peroxidation in this phase of vasospasm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193958     DOI: 10.1016/j.lfs.2004.02.010

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.

Authors:  Magdy Selim; Sharon Yeatts; Joshua N Goldstein; Joao Gomes; Steven Greenberg; Lewis B Morgenstern; Gottfried Schlaug; Michel Torbey; Bonnie Waldman; Guohua Xi; Yuko Palesch
Journal:  Stroke       Date:  2011-08-25       Impact factor: 7.914

Review 2.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

3.  High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.

Authors:  Sharon D Yeatts; Yuko Y Palesch; Claudia S Moy; Magdy Selim
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

4.  Dexanabinol prevents development of vasospasm in the rat femoral artery model.

Authors:  Ramazan Durmaz; Ahmet Ozsandik; Varol Sahintürk; Kismet Civi; Cengiz Bayçu; Hilmi Ozden; Amselem Shimon
Journal:  Neurosurg Rev       Date:  2008-02-07       Impact factor: 3.042

5.  Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage.

Authors:  Saema Ansar; Aida Maddahi; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2011-10-27       Impact factor: 3.288

Review 6.  Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH).

Authors:  Judith Weiland; Alexandra Beez; Thomas Westermaier; Ekkehard Kunze; Anna-Leena Sirén; Nadine Lilla
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

7.  CaMKII inhibition with KN93 attenuates endothelin and serotonin receptor-mediated vasoconstriction and prevents subarachnoid hemorrhage-induced deficits in sensorimotor function.

Authors:  Lars Edvinsson; Gro Klitgaard Povlsen; Hilda Ahnstedt; Roya Waldsee
Journal:  J Neuroinflammation       Date:  2014-12-10       Impact factor: 8.322

Review 8.  Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Branavan Manoranjan; Ryan C Turner; Evan McConnell; George Edward Vates; Jason D Huber; Charles L Rosen; J Marc Simard
Journal:  Int J Mol Sci       Date:  2016-04-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.